Filing metadata

Accession number
0001209191-23-041139
Form type
Form 4
Filer
VYNE Therapeutics Inc.
CIK
CIK 1566044
Filed
Jul 05, 2023
Reporting period
Jun 30, 2023
Description
Insider transaction

Explore SEC Filings Hub